Eva Åström

Publications
CV
Public outreach and news

Articles

Article: NEUROLOGY. 2024;102(2):e207948
Bisphosphonates in Glucocorticoid-Treated Patients With Duchenne Muscular Dystrophy
Landfeldt E; Phung K; Zaman F; Astrom E; Abner S; Lochmuller H; Sejersen T; Ward LM
Article: BMC MUSCULOSKELETAL DISORDERS. 2022;23(1):876
Exploring pain interference and self-perceived health status in children with osteogenesis imperfecta-a cross-sectional study
Provenzano AH; Astrom E; Lowing K
Article: CLINICAL OBSTETRICS AND GYNECOLOGY. 2021;64(4):898-903
Mesenchymal Stem Cell Therapy for Osteogenesis Imperfecta
Gotherstrom C; David AL; Walther-Jallow L; Astrom E; Westgren M
Article: CALCIFIED TISSUE INTERNATIONAL. 2021;109(2):121-131
Abnormalities in Tooth Formation after Early Bisphosphonate Treatment in Children with Osteogenesis Imperfecta
Malmgren B; Thesleff I; Dahllof G; Astrom E; Tsilingaridis G
Article: CALCIFIED TISSUE INTERNATIONAL. 2020;107(2):143-150
Bisphosphonate Therapy and Tooth Development in Children and Adolescents with Osteogenesis Imperfecta
Malmgren B; Tsilingaridis G; Monsef-Johansson N; Al Qahtani ZH; Dahllof G; Astrom E
Article: ORPHANET JOURNAL OF RARE DISEASES. 2020;15(1):80
Mutations in COL1A1/A2 and CREB3L1 are associated with oligodontia in osteogenesis imperfecta
Andersson K; Malmgren B; Astrom E; Nordgren A; Taylan F; Dahllof G
Article: BONE. 2018;114:268-277
Homozygosity for CREB3L1 premature stop codon in first case of recessive osteogenesis imperfecta associated with OASIS-deficiency to survive infancy
Lindahl K; Astrom E; Dragomir A; Symoens S; Coucke P; Larsson S; Paschalis E; Roschger P; Gamsjaeger S; Klaushofer K; Fratzl-Zelman N; Kindmark A
Article: ORPHANET JOURNAL OF RARE DISEASES. 2018;13(1):145
Dentinogenesis imperfecta type II in Swedish children and adolescents
Andersson K; Malmgren B; Astrom E; Dahllof G
Article: JOURNAL OF BONE AND MINERAL RESEARCH. 2018;33(4):753-760
Expanding the Clinical Spectrum of Phenotypes Caused by Pathogenic Variants in PLOD2
Leal GF; Nishimura G; Voss U; Bertola DR; Astrom E; Svensson J; Yamamoto GL; Hammarsjo A; Horemuzova E; Papadiogannakis N; Iwarsson E; Grigelioniene G; Tham E
Article: ORAL DISEASES. 2017;23(1):42-49
Tooth agenesis in osteogenesis imperfecta related to mutations in the collagen type I genes
Malmgren B; Andersson K; Lindahl K; Kindmark A; Grigelioniene G; Zachariadis V; Dahllof G; Astrom E
Article: PLOS ONE. 2017;12(5):e0176466
Mutations in COL1A1 and COL1A2 and dental aberrations in children and adolescents with osteogenesis imperfecta - A retrospective cohort study
Andersson K; Dahllof G; Lindahl K; Kindmark A; Grigelioniene G; Astrom E; Malmgren B
Article: BONE. 2016;87:11-18
Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate
Lindahl K; Kindmark A; Rubin C-J; Malmgren B; Grigelioniene G; Soderhall S; Ljunggren O; Astrom E
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2015;23(8):1042-1050
Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta
Lindahl K; Astrom E; Rubin C-J; Grigelioniene G; Malmgren B; Ljunggren O; Kindmark A
Article: DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY. 2015;57(5):484-490
A prospective cohort study investigating gross motor function, pain, and health-related quality of life 17 years after selective dorsal rhizotomy in cerebral palsy
Tedroff K; Lowing K; Astrom E
Article: AMERICAN JOURNAL OF MEDICAL GENETICS PART A. 2014;164(7):1635-1641
Autosomal dominant brachyolmia in a large Swedish family: Phenotypic spectrum and natural course
Grigelioniene G; Geiberger S; Horemuzova E; Mostrom E; Jantti N; Neumeyer L; Astrom E; Nordenskjold M; Nordgren A; Makitie O
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2014;3(2):255-264
Pre- and Postnatal Transplantation of Fetal Mesenchymal Stem Cells in Osteogenesis Imperfecta: A Two-Center Experience
Gotherstrom C; Westgren M; Shaw SWS; Astrom E; Biswas A; Byers PH; Mattar CNZ; Graham GE; Taslimi J; Ewald U; Fisk NM; Yeoh AEJ; Lin J-L; Cheng P-J; Choolani M; Le Blanc K; Chan JKY
Article: INTERNATIONAL JOURNAL OF MEDICAL SCIENCES. 2013;10(10):1333-1343
Allele Dependent Silencing of Collagen Type I Using Small Interfering RNAs Targeting 3'UTR Indels - a Novel Therapeutic Approach in Osteogenesis Imperfecta
Lindahl K; Kindmark A; Laxman N; Astrom E; Rubin C-J; Ljunggren O
Article: DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY. 2011;53(8):724-729
Does loss of spasticity matter? A 10-year follow-up after selective dorsal rhizotomy in cerebral palsy
Tedroff K; Lowing K; Jacobson DNO; Astrom E
Article: HORMONE RESEARCH IN PAEDIATRICS. 2011;75(5):354-361
Intravenous Pamidronate Treatment Improves Growth in Prepubertal Osteogenesis Imperfecta Patients
Heino TJ; Astrom E; Laurencikas E; Savendahl L; Soderhall S
Article: ACTA PAEDIATRICA. 2010;99(12):1834-1840
Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta
Astrom E; Magnusson P; Eksborg S; Soderhall S
Article: JOURNAL OF ORAL PATHOLOGY & MEDICINE. 2008;37(4):196-200
No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates
Malmgren B; Atrom E; Soderhall S
Article: ACTA PAEDIATRICA. 2007;96(8):1180-1183
Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta
Lowing K; Astrom E; Oscarsson KA; Soderhall S; Eliasson A-C
Article: ARCHIVES OF DISEASE IN CHILDHOOD. 2007;92(4):332-338
Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta
Astrom E; Jorulf H; Soderhall S
Article: ACTA PAEDIATRICA. 2007;96(3):446-449
Medical problems in adolescents with myelomeningocele (MMC):: an inventory of the Swedish MMC population born during 1986-1989
Olsson I; Dahl M; Mattsson S; Wendelius M; Astrom E; Westbom L
Article: TRANSPLANTATION. 2005;79(11):1607-1614
Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta
Le Blanc K; Götherström C; Ringdén O; Hassan M; McMahon R; Horwitz E; Anneren G; Axelsson O; Nunn J; Ewald U; Nordén-Lindeberg S; Jansson M; Dalton A; Åström E; Westgren M
Article: ARCHIVES OF DISEASE IN CHILDHOOD. 2002;86(5):356-364
Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta.
Aström E; Söderhäll S
Article: ACTA PAEDIATRICA. 1998;87(1):64-68
Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta
Åström E; Söderhäll S
Show more

All other publications

Letter: AMERICAN JOURNAL OF MEDICAL GENETICS PART A. 2017;173(12):3132-3135
Novel mutations in the LRP5 gene in patients with Osteoporosis-pseudoglioma syndrome
Pekkinen M; Grigelioniene G; Akin L; Shah K; Karaer K; Kurtoglu S; Ekbote A; Aycan Z; Sagsak E; Danda S; Astrom E; Makitie O
Corrigendum: EUROPEAN JOURNAL OF HUMAN GENETICS. 2015;23(8):1112
Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta.
Lindahl K; Åström E; Rubin C-J; Grigelioniene G; Malmgren B; Ljunggren Ö; Kindmark A
Meeting abstract: BONE. 2011;48:s94
Allele dependent silencing of collagen type I using small interfering RNAs targeting 3′UTR indels-A novel therapeutic approach in osteogenesis imperfecta
Lindahl K; Kindmark A; Astrom E; Rubin C-J; Ljunggren O
Thesis / dissertation: 2007
Bisphosphonate treatment of children and adolescents with osteogenesis imperfecta : effects on clinical symptoms and bone turnover
Åström, Eva

Degrees and Education

Doctor Of Philosophy, Department of Women's and Children's Health, Karolinska Institutet, 2007

Articles

All other publications

Degrees and Education

News from KI

Events from KI